Thoracic Cancer MSK 18-541

Thoracic Surgery Oncology Group (TSOG) Protocol: Registry Trial of Active Surveillance for Multifocal Ground Glass Opacities (GGOs)

The purpose of this registry study is to actively monitor people with GGOs and collect information about them, so that investigators can learn more about these lesions and about the risk of developing lung cancer in study participants whose GGOs are being monitored in the active surveillance program.

Eligibility Criteria:

  • Two or more GGO’s:
    • GGO’s must be between 0.6cm and 3cm in the greatest diameter
    • GGO’s must be >50% ground glass
  • Not being actively treated for cancer or have a history of such treatment within the last 3 years

This study is for patients age 18 and older.

Available at: Hartford Hospital, Hospital of Central Connecticut, Midstate Medical Center, William Backus Hospital.


Cancer Clinical Research Office